US FDA Panel Approval Covid-19 booster Shots for People Over 65 Years
An advisory panel of the US FDA has now given the acceptance to the novel corona virus booster vaccine shot developed be Pfizer for the people, who are more than 65 yeas along with the other people, which are at the high-risk of the disease. But on Friday, 17th September 2021, the US FDA panel […]
Continue Reading